1-6 of 428 Activities
In this CME Outfitters live Q&A, expert faculty will answer questions about the multifaceted impact of GLP-1 RA therapies on glycemic control, CV health, weight management, renal health, liver health, and overall T2D complication risk.
In this CME Outfitters Live Q&A, expert faculty and a patient advocate will answer questions on clinical experience, study information, updates to guidelines, resources, and how to integrate sensitive and respectful discussions about anal cancer risk, prevention, and screening into everyday clinical workflows to improve outcomes for patients at high risk for anal cancer.
In this CME Outfitters BriefCase, expert faculty will utilize real-world case studies to explore gaps in clinician and patient adherence to the MREMS, including discussions and/or demonstrations of counseling, pregnancy testing, acceptable contraception methods, and monitoring of confirmed pregnancies via the Mycophenolate Pregnancy Registry to support ongoing pharmacovigilance.
In this CME Outfitters Clinical Navigator, expert faculty will discuss strategies for identifying the physiologic biopsychosocial factors that influence pain, utilizing pain assessment tools that reinforce approaches to the appropriate management of pain, implementing strategies from the 2022 CDC Guideline for Prescribing Opioids into the development of safe and effective pain management plans, and other valuable skills for improving the treatment of patients suffering from chronic pain.
This third of four CME Outfitters Snacks features MASLD/MASH experts Sonal Kumar, MD, and Zobair Younossi, MD.
In this CME Outfitters recorded webcast, expert faculty will examine socioeconomic, geographic, and systemic factors that contribute to disparities in clinical trial access, particularly in underserved or community-based settings. Faculty will help learners identify interprofessional strategies, including use of culturally responsive communication, patient navigators, and advocacy partnerships, to engage underrepresented patients in clinical trial discussions and enrollment.
